Peijia Medical Stock price
Is Peijia Medical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
Peijia Medical Stock Analysis
Analyst Opinions
10 Analysts have issued a Peijia Medical forecast:
Analyst Opinions
10 Analysts have issued a Peijia Medical forecast:
Don't miss a Thing! We will send you all news about Peijia Medical directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Peijia Medical Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Suzhou, Jiangsu and currently employs 1,022 full-time employees. The company went IPO on 2020-05-15. The firm primarily operates its businesses through two segments, Transcatheter Valve Therapeutic Business segment and Neurointerventional Business segment. Transcatheter Valve Therapeutic Business segment is mainly engaged in the business of research and development, manufacturing and sales of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is mainly involved in the business of research and development, manufacturing and sales of neurointerventional procedural medical devices. The Company’s products include commercialized products such as TaurusOne and TaurusElite. The firm mainly conducts its businesses in the domestic market.
| Head office | Cayman Islands |
| CEO | Dr. Zhang |
| Employees | 1,022 |
| Website | www.peijiamedical.com |


